價(jià)格 | 詢價(jià) |
包裝 | 1盒 |
最小起訂量 | 1盒 |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-24 |
中文名稱:Elesclomol (STA-4783) | 英文名稱:Elesclomol (STA-4783) |
CAS:488832-69-5 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 488832-69-5 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
Elesclomol (STA-4783) | 10mM (in 1mL DMSO) 5mg 10mg 50mg 200mg | 488832-69-5 | EY-Y0164746 |
Cas No.488832-69-5
別名 STA 4783, STA4783
化學(xué)名 1-N',3-N'-bis(benzenecarbonothioyl)-1-N',3-N'-dimethylpropanedihydrazide
分子式 C19H20N4O2S2
分子量 400.5
溶解度 ≥ 20.15mg/mL in DMSO, ≥ 5.68 mg/mL in EtOH with ultrasonic and warming
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
Elesclomol (also known as STA-4783), originally identified in a cell-based phenotypic screen for proapoptotic activity, is a novel small-molecule that potently induces apoptosis of cancer cells through the rapid generation of reactive oxygen species (ROS) and the induction of unmanageable levels of oxidative stress. Elesclomol exhibits autitumor activity against a broad spectrum of types of cancer cell in human tumor xengograft models due to its excessive ROS production and elevated levels of oxidative stress leading to the death of cancer cells. Elesclomol is currently being studies as a novel cancer therapeutic, in which it has demonstrated ability to prolong progression-free survival in study subjects.
Reference
[1].Ronald K. Blackman, Kahlin Cheung-Ong, Marinella Gebbia, David A. Proia, Suqin He, Jane Kepros, Aurelie Jonneaux, Philippe Marchetti, Jerome Kluza, Patricia E. Rao, Yumiko Wada, Guri Giaever, Corey Nislow. Mitochondrial electron transport is the cellular target of the oncology drug elesclomol. PLoS ONE 2012; 7(1): e29798
[2].Jessica R. Kirshner, Suqin He, Vishwasenani Balasubramanyam, Jane Kepros, Chin-Yu Yang, Mei Zhang, Zhenjian Du, James Barsoum, and John Bertin. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther 2008; 7:2319-2327
成立日期 | 2014-06-05 (11年) | 注冊資本 | 100 |
員工人數(shù) | 50-100人 | 年?duì)I業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,抗體,細(xì)胞培養(yǎng),分子生物學(xué),免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥1407.38 |
上海超研生物科技有限公司
|
2024-12-08 | ||
詢價(jià) |
VIP2年
|
常州澤源醫(yī)藥科技有限公司
|
2024-12-02 | |
¥215 |
VIP12年
|
上海陶術(shù)生物科技有限公司
|
2024-12-02 | |
¥1131.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
詢價(jià) |
VIP9年
|
上海芮暉化工科技有限公司
|
2024-11-08 | |
¥6929.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2024-10-31 | |
詢價(jià) |
VIP1年
|
上海和寧美生物醫(yī)藥科技有限公司
|
2024-10-28 | |
詢價(jià) |
南京百鑫德諾生物科技有限公司
|
2024-09-26 | ||
¥1407.38 |
Selleck中國
|
2020-01-14 | ||
詢價(jià) |
Maple Chemical Co.,ltd
|
2015-01-29 |